DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression. 2017

Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
Division of Cancer Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.

Following DNA damage caused by exogenous sources, such as ionizing radiation, the tumour suppressor p53 mediates cell cycle arrest via expression of the CDK inhibitor, p21. However, the role of p21 in maintaining genomic stability in the absence of exogenous DNA-damaging agents is unclear. Here, using live single-cell measurements of p21 protein in proliferating cultures, we show that naturally occurring DNA damage incurred over S-phase causes p53-dependent accumulation of p21 during mother G2- and daughter G1-phases. High p21 levels mediate G1 arrest via CDK inhibition, yet lower levels have no impact on G1 progression, and the ubiquitin ligases CRL4Cdt2 and SCFSkp2 couple to degrade p21 prior to the G1/S transition. Mathematical modelling reveals that a bistable switch, created by CRL4Cdt2, promotes irreversible S-phase entry by keeping p21 levels low, preventing premature S-phase exit upon DNA damage. Thus, we characterize how p21 regulates the proliferation-quiescence decision to maintain genomic stability.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D016193 G1 Phase The period of the CELL CYCLE preceding DNA REPLICATION in S PHASE. Subphases of G1 include "competence" (to respond to growth factors), G1a (entry into G1), G1b (progression), and G1c (assembly). Progression through the G1 subphases is effected by limiting growth factors, nutrients, or inhibitors. First Gap Phase,G1a Phase,G1b Phase,Gap Phase 1,First Gap Phases,G1 Phases,G1a Phases,G1b Phases,Gap Phase, First,Gap Phases, First,Phase 1, Gap,Phase, First Gap,Phase, G1,Phase, G1a,Phase, G1b,Phases, First Gap,Phases, G1,Phases, G1a,Phases, G1b
D016196 S Phase Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome. S Period,Period, S,Periods, S,Phase, S,Phases, S,S Periods,S Phases
D042822 Genomic Instability An increased tendency of the GENOME to acquire MUTATIONS when various processes involved in maintaining and replicating the genome are dysfunctional. Genome Instability,Genome Stability,Genomic Stability,Genome Instabilities,Genome Stabilities,Genomic Instabilities,Genomic Stabilities,Instabilities, Genome,Instabilities, Genomic,Instability, Genome,Instability, Genomic,Stabilities, Genome,Stabilities, Genomic,Stability, Genome,Stability, Genomic
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D049452 Green Fluorescent Proteins Protein analogs and derivatives of the Aequorea victoria green fluorescent protein that emit light (FLUORESCENCE) when excited with ULTRAVIOLET RAYS. They are used in REPORTER GENES in doing GENETIC TECHNIQUES. Numerous mutants have been made to emit other colors or be sensitive to pH. Green Fluorescent Protein,Green-Fluorescent Protein,Green-Fluorescent Proteins,Fluorescent Protein, Green,Fluorescent Proteins, Green,Protein, Green Fluorescent,Protein, Green-Fluorescent,Proteins, Green Fluorescent,Proteins, Green-Fluorescent

Related Publications

Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
January 2008, Molecular biology of the cell,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
January 2019, OncoTargets and therapy,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
December 2013, Science signaling,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
October 2010, Cell cycle (Georgetown, Tex.),
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
May 2019, European journal of pharmacology,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
December 2001, Current opinion in cell biology,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
December 2020, Immunity, inflammation and disease,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
April 2019, Cell cycle (Georgetown, Tex.),
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
May 2018, Gene,
Alexis R Barr, and Samuel Cooper, and Frank S Heldt, and Francesca Butera, and Henriette Stoy, and Jörg Mansfeld, and Béla Novák, and Chris Bakal
July 2003, The Journal of surgical research,
Copied contents to your clipboard!